Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 14, 2019

SELL
$220.1 - $309.0 $196,989 - $276,555
-895 Closed
0 $0
Q3 2018

Nov 13, 2018

SELL
$289.28 - $326.15 $62,195 - $70,122
-215 Reduced 19.37%
895 $280,000
Q2 2018

Aug 13, 2018

SELL
$244.1 - $303.88 $588,281 - $732,350
-2,410 Reduced 68.47%
1,110 $320,000
Q1 2018

May 11, 2018

BUY
$233.97 - $274.11 $823,574 - $964,867
3,520 New
3,520 $880,000
Q4 2017

Feb 02, 2018

SELL
$216.94 - $271.3 $34,710 - $43,408
-160 Closed
0 $0
Q3 2017

Nov 13, 2017

SELL
$212.27 - $242.28 $4.05 Million - $4.62 Million
-19,075 Reduced 99.17%
160 $36,000
Q2 2017

Aug 14, 2017

BUY
N/A
19,235
19,235 $4.35 Million

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.47B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track C M Bidwell & Associates LTD Portfolio

Follow C M Bidwell & Associates LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of C M Bidwell & Associates LTD, based on Form 13F filings with the SEC.

News

Stay updated on C M Bidwell & Associates LTD with notifications on news.